# A Study of An Adjuvanted Inactivated H7N9 Influenza Vaccine

> **NCT03755427** · PHASE2 · COMPLETED · sponsor: **Shanghai Institute Of Biological Products** · enrollment: 560 (actual)

## Conditions studied

- H7N9 Influenza

## Interventions

- **BIOLOGICAL:** 15μg H7N9 Vaccine
- **BIOLOGICAL:** Aluminum Hydroxide Adjuvant

## Key facts

- **NCT ID:** NCT03755427
- **Lead sponsor:** Shanghai Institute Of Biological Products
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-11-10
- **Primary completion:** 2019-01-05
- **Final completion:** 2019-11-15
- **Target enrollment:** 560 (ACTUAL)
- **Last updated:** 2024-10-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03755427

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03755427, "A Study of An Adjuvanted Inactivated H7N9 Influenza Vaccine". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03755427. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*